S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
Most-Downgraded StocksMost-Downgraded
NASDAQ:BIIB

Biogen (BIIB) Earnings Date, Estimates & Call Transcripts

$257.68
-1.25 (-0.48%)
(As of 09/22/2023 ET)
Compare
Today's Range
$257.09
▼
$260.72
50-Day Range
$253.30
▼
$278.40
52-Week Range
$194.45
▼
$319.76
Volume
800,827 shs
Average Volume
723,311 shs
Market Capitalization
$37.32 billion
P/E Ratio
14.03
Dividend Yield
N/A
Price Target
$325.36
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Oct. 24Estimated
Actual EPS
(Jul. 25)
$4.02 Beat By $0.25
Consensus EPS
(Jul. 25)
$3.77
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BIIB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIIB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Biogen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20236$2.16$3.64$3.28 
Q2 20238$3.59$3.91$3.72 
Q3 20237$3.56$4.10$3.92 
Q4 20238$3.46$4.39$4.02 
FY 202329$12.77$16.04$14.93 
Q1 20243$3.26$3.79$3.55 
Q2 20243$3.77$4.53$4.11 
Q3 20243$3.54$4.48$4.16 
Q4 20243$3.49$5.41$4.54 
FY 202412$14.06$18.21$16.36 
Q1 20252$3.73$5.34$4.54 

BIIB Earnings Date and Information

Biogen last posted its quarterly earnings results on July 25th, 2023. The biotechnology company reported $4.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.77 by $0.25. The company earned $2.46 billion during the quarter, compared to analyst estimates of $2.36 billion. Its quarterly revenue was down 5.1% on a year-over-year basis. Biogen has generated $18.37 earnings per share over the last year ($18.37 diluted earnings per share) and currently has a price-to-earnings ratio of 14.0. Earnings for Biogen are expected to grow by 6.89% in the coming year, from $15.25 to $16.30 per share. Biogen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 24th, 2023 based off prior year's report dates.

Biogen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/24/2023
Estimated)		------- 
7/25/2023Q2 2023$3.77$4.02+$0.25$3.97$2.36 billion$2.46 billion    
4/25/2023Q1 2023$3.25$3.40+$0.15$4.13$2.34 billion$2.46 billion      
2/15/2023Q4 2022$3.48$4.05+$0.57$4.31$2.44 billion$2.54 billion    
10/25/2022Q3 2022$4.13$4.77+$0.64$1.70$2.47 billion$2.51 billion      
7/20/2022Q2 2022$4.09$5.25+$1.16$3.26$2.48 billion$2.59 billion      
5/3/2022Q1 2022$4.41$3.62($0.79)$5.18$2.50 billion$2.53 billion    
2/3/2022Q4 2021$3.32$3.39+$0.07$4.28$2.62 billion$2.73 billion    
10/19/2021Q3 2021$4.09$4.77+$0.68$7.32$2.67 billion$2.78 billion    
7/21/2021Q2 2021$4.55$5.68+$1.13$8.37$2.61 billion$2.78 billion    
4/21/2021Q1 2021$5.06$5.34+$0.28$7.99$2.67 billion$2.69 billion    
2/2/2021Q4 2020$4.87$4.58($0.29)$6.84$2.80 billion$2.85 billion  
10/21/2020Q3 2020$8.06$8.84+$0.78$13.22$3.34 billion$3.38 billion    












Biogen Earnings - Frequently Asked Questions

When is Biogen's earnings date?

Biogen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 24th, 2023 based off last year's report dates. Learn more on BIIB's earnings history.

Did Biogen beat their earnings estimates last quarter?

In the previous quarter, Biogen (NASDAQ:BIIB) reported $4.02 earnings per share (EPS) to beat the analysts' consensus estimate of $3.77 by $0.25. Learn more on analysts' earnings estimate vs. BIIB's actual earnings.

How can I listen to Biogen's earnings conference call?

The conference call for Biogen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Biogen's conference call transcript?

The conference call transcript for Biogen's latest earnings report can be read online. Read Transcript

How much revenue does Biogen generate each year?

Biogen (NASDAQ:BIIB) has a recorded annual revenue of $10.17 billion.

How much profit does Biogen generate each year?

Biogen (NASDAQ:BIIB) has a recorded net income of $3.05 billion. BIIB has generated $18.37 earnings per share over the last four quarters.

What is Biogen's price-to-earnings ratio?

Biogen (NASDAQ:BIIB) has a trailing price-to-earnings ratio of 14.03 and a forward price-to-earnings ratio of 16.90. The price/earnings-to-growth ratio is 2.79.

What is Biogen's EPS forecast for next year?

Biogen's earnings are expected to grow from $15.25 per share to $16.30 per share in the next year, which is a 6.89% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BIIB) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -